<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="protein within the ORF3 band, a secreted protein with an" exact="alpha" post="helix and beta-sheet with six strands encoded by ORF8"/>
 <result pre="(244), hypoalbuminemia, and an increase of lactate dehydrogenase, aspartate transaminase," exact="alanine" post="aminotransferase, bilirubin, and, especially, D-dimer (244). Middle-aged and elderly"/>
 <result pre="consequences with regard to the high spread of this virus." exact="Ethanol" post="and disinfectants containing chlorine or bleach are effective against"/>
 <result pre="additional clinical trials (187, 281). A controlled trial of ritonavir-boosted" exact="lopinavir" post="and interferon alpha 2b treatment was performed on COVID-19"/>
 <result pre="(187, 281). A controlled trial of ritonavir-boosted lopinavir and interferon" exact="alpha" post="2b treatment was performed on COVID-19 hospitalized patients (ChiCTR2000029308)"/>
 <result pre="COVID-19 hospitalized patients (ChiCTR2000029308) (188). In addition, the use of" exact="hydroxychloroquine" post="and tocilizumab for their potential role in modulating inflammatory"/>
 <result pre="to remdesivir and favipiravir (broad-spectrum antiviral drugs) revealed remdesivir and" exact="chloroquine" post="to be highly effective against SARS-CoV-2 infection in vitro"/>
 <result pre="in vitro to lessen the viral infection. Both remdesivir and" exact="chloroquine" post="are being used in humans to treat other diseases,"/>
 <result pre="identified that drugs such as ribavirin, remdesivir, galidesivir, tenofovir, and" exact="sofosbuvir" post="bind RdRp tightly, indicating their vast potential to be"/>
 <result pre="study has proven that remdesivir has better antiviral activity than" exact="lopinavir" post="and ritonavir. Further, in vivo studies conducted in mice"/>
 <result pre="of disease in the event of a new coronavirus outbreak." exact="Chloroquine" post="is an antimalarial drug known to possess antiviral activity"/>
 <result pre="a recent multicenter clinical trial that was conducted in China," exact="chloroquine" post="phosphate was found to exhibit both efficacy and safety"/>
 <result pre="drug, gave promising results. The COVID-19 patients received 600â€‰mg of" exact="hydroxychloroquine" post="daily along with azithromycin as a single-arm protocol. This"/>
 <result pre="The COVID-19 patients received 600â€‰mg of hydroxychloroquine daily along with" exact="azithromycin" post="as a single-arm protocol. This protocol was found to"/>
 <result pre="of the main disadvantages that limit the clinical utility of" exact="ivermectin" post="is its potential to cause cytotoxicity. However, altering the"/>
 <result pre="modified, thereby having significant control over the systemic concentration of" exact="ivermectin" post="(338). Based on the pharmacokinetic simulation, it was also"/>
 <result pre="Based on the pharmacokinetic simulation, it was also found that" exact="ivermectin" post="may have limited therapeutic utility in managing COVID-19, since"/>
 <result pre="large-scale antiviral response against SARS-CoV-2 (341). Further, a combination of" exact="ivermectin" post="and hydroxychloroquine might have a synergistic effect, since ivermectin"/>
 <result pre="response against SARS-CoV-2 (341). Further, a combination of ivermectin and" exact="hydroxychloroquine" post="might have a synergistic effect, since ivermectin reduces viral"/>
 <result pre="of ivermectin and hydroxychloroquine might have a synergistic effect, since" exact="ivermectin" post="reduces viral replication, while hydroxychloroquine inhibits the entry of"/>
 <result pre="have a synergistic effect, since ivermectin reduces viral replication, while" exact="hydroxychloroquine" post="inhibits the entry of the virus in the host"/>
 <result pre="as well as the clinical utility of this promising drug." exact="Nafamostat" post="is a potent inhibitor of MERS-CoV that acts by"/>
 <result pre="doi:10.1126/science.1087139.12958366 79.Monchatre-LeroyE, BoueF, BoucherJM, RenaultC, MoutouF, Ar GouilhM, UmhangG2017Identification of" exact="alpha" post="and beta coronavirus in wildlife species in France: bats,"/>
 <result pre="BushmakerT, MartellaroC, BaselerL, BeneckeAG, KatzeMG, MunsterVJ, FeldmannH2013Treatment with interferon-Î±2b and" exact="ribavirin" post="improves outcome in MERS-CoV-infected rhesus macaques. Nat Med19:1313â€&quot;1317. doi:10.1038/nm.3362.24013700"/>
 <result pre="CaoR, ZhangL, YangX, LiuJ, XuM, ShiZ, HuZ, ZhongW, XiaoG2020Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 <result pre="coronavirus infection and spread. Virol J2:69. doi:10.1186/1743-422X-2-69.16115318 197.GaoJ, TianZ, YangX2020Breakthrough:" exact="chloroquine" post="phosphate has shown apparent efficacy in treatment of COVID-19"/>
 <result pre="J Med Virol92:667â€&quot;674. doi:10.1002/jmv.25762.32167180 261.ColsonP, RolainJM, LagierJC, BrouquiP, RaoultD2020Chloroquine and" exact="hydroxychloroquine" post="as available weapons to fight COVID-19. Int J Antimicrob"/>
 <result pre="GiarratanoA, EinavS2020A systematic review on the efficacy and safety of" exact="chloroquine" post="for the treatment of COVID-19. Crit Care57:279â€&quot;283. doi:10.1016/j.jcrc.2020.03.005. 263.DevauxCA,"/>
 <result pre="263.DevauxCA, RolainJM, ColsonP, RaoultD2020New insights on the antiviral effects of" exact="chloroquine" post="against coronavirus: what to expect for COVID-19?Int J Antimicrob"/>
 <result pre="doi:10.1016/j.ijantimicag.2020.105938.32171740 264.SahraeiZ, ShabaniM, ShokouhiS, SaffaeiA2020Aminoquinolines against coronavirus disease 2019 (COVID-19):" exact="chloroquine" post="or hydroxychloroquine. Int J Antimicrob Agents55:105945. doi:10.1016/j.ijantimicag.2020.105945.32194152 265.TouretF, de"/>
 <result pre="or hydroxychloroquine. Int J Antimicrob Agents55:105945. doi:10.1016/j.ijantimicag.2020.105945.32194152 265.TouretF, de LamballerieX2020Of" exact="chloroquine" post="and COVID-19. Antiviral Res177:104762. doi:10.1016/j.antiviral.2020.104762.32147496 266.YaoX, YeF, ZhangM, CuiC,"/>
 <result pre="vitro antiviral activity and projection of optimized dosing design of" exact="hydroxychloroquine" post="for the treatment of severe acute respiratory syndrome coronavirus"/>
 <result pre="267.ZhouD, DaiSM, TongQ2032020COVID-19: a recommendation to examine the effect of" exact="hydroxychloroquine" post="in preventing infection and progression. J Antimicrob Chemother doi:10.1093/jac/dkaa114."/>
 <result pre="of Guangdong Province and Health Commission of Guangdong Province for" exact="Chloroquine" post="in the Treatment of Novel Coronavirus. 2020Expert consensus on"/>
 <result pre="Chloroquine in the Treatment of Novel Coronavirus. 2020Expert consensus on" exact="chloroquine" post="phosphate for the treatment of novel coronavirus pneumonia. Zhonghua"/>
 <result pre="DupontHT, HonorÃ©S, ColsonP, ChabriÃ¨reE, La ScolaB, RolainJM, BrouquiP, RaoultD2032020Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
 <result pre="rapid antiviral clearance or clinical benefit with the combination of" exact="hydroxychloroquine" post="and azithromycin in patients with severe COVID-19 infection. Med"/>
 <result pre="clearance or clinical benefit with the combination of hydroxychloroquine and" exact="azithromycin" post="in patients with severe COVID-19 infection. Med Mal Infect50:384."/>
 <result pre="Mal Infect50:384. doi:10.1016/j.medmal.2020.03.006.32240719 308.CalyL, DruceJD, CattonMG, JansDA, WagstaffKM2020The FDA-approved drug" exact="ivermectin" post="inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res178:104787."/>
 <result pre="Am Acad Dermatol82:e221. doi:10.1016/j.jaad.2020.04.017.32283237 340.SchmithVD, ZhouJJ, LohmerLR2020The approved dose of" exact="ivermectin" post="alone is not the ideal dose for the treatment"/>
</results>
